3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
12
Hematologic Neoplasms
7
Lymphoma
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia
5
Graft vs Host Disease
5
Primary Myelofibrosis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Burkitt Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Interventions
Carboplatin
3
durvalumab
2
Tretinoin
2
Paclitaxel
2
Irinotecan
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Surgical Procedures, Operative
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Tacrolimus
×
90 days
×
Clear all
No trials found.